---
schema_version: "secwatch.filing_event.v1"
accession: "0001860742-25-000003"
form_type: "8-K"
ticker: "BLCO"
cik: "0001860742"
company_name: "Bausch & Lomb Corp"
filed_at: "2025-02-19T23:59:59+00:00"
generated_at: "2026-05-26T12:30:07.476362+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bausch + Lomb Q4 revenue up 11% CC; FY GAAP loss widens; guides 2025 revenue ~$5B

## Summary
- Q4 revenue $1.28B, up 9% reported and 11% constant currency, with growth across all segments.
- FY GAAP net loss attributable $317M vs $260M loss in 2023; adjusted net income $204M vs $258M.
- Adjusted EBITDA ex Acquired IPR&D FY $878M (+$140M); Q4 $259M (+$28M).
- 2025 guidance: revenue $4.95B-$5.05B (~5.5%-7.5% CC growth); Adj. EBITDA $900M-$950M; FX headwinds ~$100M revenue.
- Dry eye portfolio approaching $1B annual revenue; contact lens double-digit Q4 growth; XIIDRA/MIEBO driving pharma.

## SEC filing metadata
- accession: 0001860742-25-000003
- form_type: 8-K
- ticker: BLCO
- cik: 0001860742
- company_name: Bausch & Lomb Corp
- filed_at: 2025-02-19T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860742/000186074225000003/0001860742-25-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860742/000186074225000003/blco-20250219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001860742-25-000003
- JSON: https://secwatch.observer/filing/0001860742-25-000003.json
- Plain text: https://secwatch.observer/filing/0001860742-25-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.